<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJMI</journal-id><journal-title-group><journal-title>Open Journal of Medical Imaging</journal-title></journal-title-group><issn pub-type="epub">2164-2788</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojmi.2024.141001</article-id><article-id pub-id-type="publisher-id">OJMI-131052</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Contribution of Bone Scintigraphy in the Diagnosis of a Case of SAPHO in the Nuclear Medicine Department of Idrissa Pouye General Hospital (Dakar, Senegal)
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>El</surname><given-names>Hadji Amadou Lamine Bathily</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kalidou</surname><given-names>Gueye</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Serigne</surname><given-names>Moussa Badiane</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mamoudou</surname><given-names>Salif Djigo</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Gora</surname><given-names>Thiaw</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ousseynou</surname><given-names>Diop</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Olatounde</surname><given-names>Herbert Fachinan</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Papa</surname><given-names>Mady Sy</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Alfonse</surname><given-names>Rodrigue Djiboune</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kokou</surname><given-names>Fofo Toussaint Adambounou</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Louis</surname><given-names>Augustin Diaga Diouf</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Boucar</surname><given-names>Ndong</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Gora</surname><given-names>Mbaye</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Omar</surname><given-names>Ndoye</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mounibé</surname><given-names>Diarra</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mamadou</surname><given-names>Mbodj</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff4"><addr-line>Nuclear Medicine Department, Hospital Dalal Jamm, Dakar, Senegal</addr-line></aff><aff id="aff2"><addr-line>Biophysical Laboratory, UFR2S, Gaston Berger University (UGB), Saint-Louis, Senegal</addr-line></aff><aff id="aff1"><addr-line>Nuclear Medicine Department, Idrissa Pouye General Hospital (HOGIP), Dakar, Senegal</addr-line></aff><aff id="aff6"><addr-line>Biophysical Laboratory, University of Lome, Lome, Togo</addr-line></aff><aff id="aff5"><addr-line>Laboratory of Physical and Pharmaceutical Biophysics, FMPO, Cheikh Anta Diop University, Dakar, Senegal</addr-line></aff><aff id="aff3"><addr-line>Biophysical Laboratory, FMPO, Cheikh Anta Diop University (UCAD), Dakar, Senegal</addr-line></aff><pub-date pub-type="epub"><day>05</day><month>02</month><year>2024</year></pub-date><volume>14</volume><issue>01</issue><fpage>1</fpage><lpage>9</lpage><history><date date-type="received"><day>12,</day>	<month>December</month>	<year>2023</year></date><date date-type="rev-recd"><day>2,</day>	<month>February</month>	<year>2024</year>	</date><date date-type="accepted"><day>5,</day>	<month>February</month>	<year>2024</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Introduction: The acronym SAPHO (Synovitis, Acne, Pustulosis, Hyperostosis and Osteitis) is a syndrome combining osteoarticular and cutaneous manifestations. It occurs mainly between the ages of 30 and 50. Sternocostoclavicular hyperostosis is one of the main distinguishing features. We report a case of SAPHO in Dakar diagnosed by bone scintigraphy. 
  Observation: 28-year-old Senegalese women presented with left shoulder pain and relative functional impotence for over 2 years. Examination revealed right sternoclavicular hyperostosis and left shoulder pain on palpation. Questioning revealed a history of acne and hyperostosis of the right first toe. Bone scintigraphy, performed after injection of 630 MBq of 
  <sup>99m</sup>Tc-HMDP, revealed: hyperfixation of the bilateral (right++) manubrio-sternal and sternoclavicular junction, producing the classic bull’s horn image; hyperfixation of the left shoulder with an inflammatory appearance; hyperfixation of the sacroiliac joints suggestive of bilateral sacroiliitis; hyperfixation of the right first toe; two mandibular hyper fixations probably related to dental damage. This scintigraphic appearance in one was strongly suggestive of SAPHO syndrome. 
  Conclusion: SAPHO syndrome, related to spondyloarthropathy, associates cutaneous and osteoarticular signs. It is characterized by frequent delays in diagnosis due to poor recognition. Soy is an invaluable diagnostic tool, enabling us to assess the extent of the disease and its evolution.
 
</p></abstract><kwd-group><kwd>SAPHO</kwd><kwd> Bone Scintigraphy</kwd><kwd> Young Woman</kwd><kwd> Senegalese</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>SAPHO (synovitis, acne, pustulosis, hyperostosis, and osteitis) syndrome is a rare entity that combines a heterogeneous set of cutaneous and osteoarticular manifestations, with a common aseptic inflammatory process. It associates osteoarticular disorders (synovitis, hyperostosis, osteitis), essentially sternocostoclavicular, with skin abnormalities (acne, pustulosis) [<xref ref-type="bibr" rid="scirp.131052-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.131052-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.131052-ref3">3</xref>] .</p><p>SAPHO syndrome is known as “Skibo-disease” (short for skin-bone), i.e. a combination of bone and joint manifestations linked to dermatological signs [<xref ref-type="bibr" rid="scirp.131052-ref2">2</xref>] .</p><p>It is a painful and disabling disease that affects women more frequently than men [<xref ref-type="bibr" rid="scirp.131052-ref2">2</xref>] .</p><p>The etiopathogenesis of this syndrome remains debated. While some consider it to be a spondyloarthropathy, others consider it to be of infectious origin. Diagnosis is based on the presence of at least one of the three diagnostic criteria proposed by Kahn [<xref ref-type="bibr" rid="scirp.131052-ref1">1</xref>] .</p><p>This syndrome is considered rare, occurring mainly in young adults between the ages of 30 and 50. In adults, sternocostoclavicular hyperostosis is one of the main distinguishing features.</p><p>Diagnosis is based on a combination of clinicobiological and radiological criteria, and may be pathognomonic on bone scintigraphy [<xref ref-type="bibr" rid="scirp.131052-ref4">4</xref>] . Bone scintigraphy (BS) with <sup>99m</sup>Tc-HMDP is an invaluable diagnostic tool, as radiotracer fixation can precede clinical and even radiological manifestations, particularly in the anterior thorax [<xref ref-type="bibr" rid="scirp.131052-ref5">5</xref>] .</p><p>We report a case of SAPHO diagnosed on bone scintigraphy at the nuclear medicine department of Idrissa Pouye General Hospital in Dakar.</p></sec><sec id="s2"><title>2. Observation</title><p>This was a 28-year-old Senegalese woman presenting with left shoulder pain and relative functional impotence for over 2 years. This condition had prompted several consultations, notably in neurology, orthopaedics and rheumatology, with transient remissions.</p><p>Examination revealed hyperostosis of the right sternoclavicular joint (<xref ref-type="fig" rid="fig1">Figure 1</xref>) and left shoulder (<xref ref-type="fig" rid="fig2">Figure 2</xref>), painful on palpation and mobilization. Questioning revealed a history of acne and hyperostosis of the right first toe.</p><p>The biological workup, carried out two months in advance, showed a discrete inflammatory syndrome with a C-reactive protein elevated to 7 mg/L (normal &lt; 6 mg/L), a sedimentation rate of 15 mm at the first hour, and an absence of infectious syndrome with a white blood cell count equal to 6.1.103/mm<sup>3</sup> (norms: 4.103 to 10.10/mm<sup>3</sup>). Calcemia was normal at 93 mg/l (84 - 102 mg/l). The blood culture was negative and no bacteria were found on bacteriological examination.</p><p>Shoulder ultrasound and spinal cord MRI (absence of bone erosion and synovitis) were normal.</p><p>Hand and chest X-rays (absence of hyperostosis, condensing lesions and osteolytic lesions) were also unremarkable.</p><p>In this context, whole-body bone scintigraphy (anterior and posterior) was performed 3 hours after injection of 630 MBq of <sup>99m</sup>Tc-HMDP, using a SPECT gamma camera (dual-head, Mediso Nucline TM Spirit DH-V type). It revealed:</p><p>- Hyperfixation of the bilateral (right +++) manubrio-sternal and sternoclavicular junction, producing the classic bull’s horn image (<xref ref-type="fig" rid="fig3">Figure 3</xref>);</p><p>- Inflammatory hyperfixation of the left shoulder;</p><p>- Hyperfixation of the sacroiliac joints, suggestive of bilateral sacroiliitis (<xref ref-type="fig" rid="fig4">Figure 4</xref>);</p><p>- Hyperfixation of the right first toe (<xref ref-type="fig" rid="fig5">Figure 5</xref>);</p><p>- Strengthening the fixation of the pubic symphysis and dorsolumbar spine;</p><p>- Two mandibular hyperfixations (<xref ref-type="fig" rid="fig5">Figure 5</xref>).</p><p>This bull’s horn scintigraphic appearance, in a context of hyperostosis and a history of acne, was strongly suggestive of SAPHO syndrome.</p><p>The thoracic CT scan, in comparison with the bone scan, was performed 24 hours later, and found no abnormalities (absence of hyperostosis and signs of osteitis).</p><p>His treatment included analgesics, anti-inflammatories and physiotherapy, with significant improvement in functional impotence of the left shoulder.</p></sec><sec id="s3"><title>3. Discussion</title><p>The origin of SAPHO syndrome is unknown, but it is generally considered to be an auto-inflammatory disease, i.e. due to a deregulation of innate immunity, as opposed to autoimmune diseases in which it is the acquired/adaptive immunity system that is deregulated [<xref ref-type="bibr" rid="scirp.131052-ref6">6</xref>] .</p><p>The frequency of this pathology is very low, which is why studies on it are rare, and randomized controlled trials on the subject are totally non-existent. As a result, the pathophysiology and efficacy of various treatments are poorly understood. This is particularly problematic when it comes to drawing up recommendations for diagnosis and therapeutic strategies. In fact, there are no official recommendations [<xref ref-type="bibr" rid="scirp.131052-ref6">6</xref>] .</p><p>Our patient was a 28-year-old Senegalese woman. It is reported in the literature that SAPHO syndrome affects more young adults between 30 and 50 years of age [<xref ref-type="bibr" rid="scirp.131052-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.131052-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.131052-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.131052-ref8">8</xref>] .</p><p>The average age of onset of the first symptoms is between 35.8 and 38.5 years; they almost never appear after the age of 60, and the average diagnosis is made at around 45.5 years [<xref ref-type="bibr" rid="scirp.131052-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.131052-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.131052-ref10">10</xref>] . Our patient was diagnosed slightly earlier, at the age of 28. However, this syndrome does not spare the elderly, according to Chamot A. M. et al. [<xref ref-type="bibr" rid="scirp.131052-ref11">11</xref>] .</p><p>C. Ghomari reported a case of SAPHO in a 56-year-old patient [<xref ref-type="bibr" rid="scirp.131052-ref4">4</xref>] . Occurrence in children is rare, but possible [<xref ref-type="bibr" rid="scirp.131052-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.131052-ref3">3</xref>] .</p><p>Female predilection is also described in the literature [<xref ref-type="bibr" rid="scirp.131052-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.131052-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.131052-ref11">11</xref>] .</p><p>However, according to I. Gharsallah [<xref ref-type="bibr" rid="scirp.131052-ref1">1</xref>] and Assia Haddouche [<xref ref-type="bibr" rid="scirp.131052-ref7">7</xref>] , it affects both sexes equally, with a sex ratio close to 1.</p><p>This is the second case of SAPHO in Senegal diagnosed by bone scintigraphy, following that of NDong Boucar et al. in 2010 [<xref ref-type="bibr" rid="scirp.131052-ref8">8</xref>] .</p><p>Globally, the prevalence of SAPHO syndrome is poorly known, with probable variations from one continent to another [<xref ref-type="bibr" rid="scirp.131052-ref12">12</xref>] . According to Sophie Przybylowski [<xref ref-type="bibr" rid="scirp.131052-ref6">6</xref>] , the prevalence does not exceed 1/10,000 worldwide and in the global Caucasian population. It is probably underestimated due to the relatively recent individualization of the disease and a lack of knowledge of all its components [<xref ref-type="bibr" rid="scirp.131052-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.131052-ref7">7</xref>] . In France, it is estimated to affect 1 in 50,000 people [<xref ref-type="bibr" rid="scirp.131052-ref6">6</xref>] . The syndrome appears to be more prevalent in the Caucasian population, although some studies have focused on other populations, notably Japanese and North African [<xref ref-type="bibr" rid="scirp.131052-ref6">6</xref>] . According to Assia Haddouche, SAPHO syndrome has mainly been described in Japan and Northern Europe, but rarely in Anglo-Saxon countries [<xref ref-type="bibr" rid="scirp.131052-ref7">7</xref>] .</p><p>In our case, the clinical picture was dominated, as widely described in the literature, by osteoarticular manifestations (painful hyperostosis of the right sternoclavicular joint, left shoulder and big toe) and dermatological manifestations with a history of acne. In fact, the manifestations are primarily cutaneous and osteoarticular [<xref ref-type="bibr" rid="scirp.131052-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.131052-ref12">12</xref>] .</p><p>The diagnosis was made on the basis of the following arguments:</p><p>- Clinical: anterior thoracic swelling tender to palpation, localized in the right sternoclavicular region (most frequent localization) and the notion of acne one year ago (skin involvement in SAPHO syndrome may precede bone involvement with a delay of one to two years, up to 20 years);</p><p>- Para-clinical findings in favour of chronic aseptic inflammatory osteitis based on an inflammatory syndrome, with absence of hyperleukocytosis on biology, negative blood culture on bacteriological examination and the very characteristic bull’s horn appearance on bone scintigraphy [<xref ref-type="bibr" rid="scirp.131052-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.131052-ref14">14</xref>] .</p><p>Anterior thoracic involvement is one of the main distinguishing features of SAPHO syndrome. In the mono-centric series from Bichat hospital, its prevalence was measured at 63%. Earlier, several publications had already drawn attention to the elective involvement of the sternocostoclavicular region, with prevalence as high as 100% for Sonozaki et al. [<xref ref-type="bibr" rid="scirp.131052-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.131052-ref15">15</xref>] .</p><p>I Gharsallah [<xref ref-type="bibr" rid="scirp.131052-ref1">1</xref>] estimates the frequency of articular damage to the anterior thoracic wall at 65% - 90%, affecting all anatomical components, but in particular the medial fragment of the clavicle. It manifests as inflammatory pain in the anterior-upper part of the thorax, which may radiate to the neck and shoulders [<xref ref-type="bibr" rid="scirp.131052-ref1">1</xref>] .</p><p>Clinically, the initial signs consist of an inflammatory, painful swelling involving one or two anterior chest wall joints, primarily sternoclavicular, less frequently manubrio-sternal or chondrosternal. Patients frequently describe irradiation to the shoulder or trapezius, sometimes exclusively in the case of sternoclavicular involvement. More rarely, the initial area of pain is centred on one of the bony parts (clavicle, sternum), with later swelling resulting from the spread of osteitis to the adjacent soft tissues. Secondly, the almost systematic transition to chronicity leads to a progressive extension of inflammatory phenomena, with the dual characteristic of inducing erosive joint damage and, above all, bone hypertrophy, sometimes considerable. The latter primarily affects the clavicles, with the formation of hyperostosis and periostosis, sometimes of major proportions, which may themselves be complicated by compression and then subclavian phlebothrombosis, with possible collateral circulation [<xref ref-type="bibr" rid="scirp.131052-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.131052-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.131052-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.131052-ref17">17</xref>] .</p><p>Along with sacroiliac involvement, this type of manifestation obviously supports the diagnosis of spondyloarthropathy, and usually indicates greater severity. However, this axial involvement may also remain clinically silent, only to be detected by various imaging techniques [<xref ref-type="bibr" rid="scirp.131052-ref12">12</xref>] .</p><p>In 1994, Kahn et al. defined three criteria for diagnosis:</p><p>- Aseptic multifocal osteomyelitis, with or without skin lesions;</p><p>- Acute or chronic joint involvement associated with palmoplantar pustulosis, palmoplantar pustular psoriasis or severe acne;</p><p>- Aseptic mono- or polyostotic osteitis associated with palmoplantar pustulosis, palmoplantar pustular psoriasis, and severe acne.</p><p>The presence of just one of these criteria is sufficient to establish the diagnosis. However, the appearance of dermatological signs makes it easier to establish the diagnosis.</p><p>Biological blood tests are especially useful for diagnosing pathologies associated with the syndrome, such as chronic inflammatory bowel disease [<xref ref-type="bibr" rid="scirp.131052-ref3">3</xref>] .</p><p>Tc99m bone scintigraphy is an invaluable diagnostic tool, as isotope fixation can precede clinical and even radiological manifestations, particularly in the anterior thorax [<xref ref-type="bibr" rid="scirp.131052-ref5">5</xref>] .</p><p>On scintigraphy, all these bone foci, which correspond to foci of aseptic osteitis, strongly fix the tracer. Scintigraphy can guide the diagnosis when it reveals foci on the clavicle and sternum, with the classic bull’s horn appearance [<xref ref-type="bibr" rid="scirp.131052-ref8">8</xref>] . So is also very useful for assessing the extent of the disease and its evolution [<xref ref-type="bibr" rid="scirp.131052-ref15">15</xref>] .</p><p>Skin biopsies are rarely performed, but can be useful in eliminating infectious causes, particularly staphylococcal infections. If the biopsy reveals the presence of P. acnes in the skin lesions, the doctor will preferentially prescribe the antibiotics classically used in acne [<xref ref-type="bibr" rid="scirp.131052-ref6">6</xref>] .</p><p>The etiopathogenesis of SAPHO syndrome remains mysterious or poorly understood [<xref ref-type="bibr" rid="scirp.131052-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.131052-ref7">7</xref>] . However, certain mechanisms seem to be becoming clearer, in particular, the terrain of onset and the role of certain infectious agents. Propionibacterium acnes has been incriminated in SAPHO syndrome, since it has been isolated within bone lesions. In the series by Assman et al., it was isolated from 67% of patients undergoing bone biopsy. However, this infectious theory remains controversial, partly because P. acnes is often found to be negative by polymerase chain reaction (PCR), and partly because of the inconsistent efficacy of antibiotics and the non-aggravation of lesions after corticosteroid infiltration. A German team has demonstrated strong expression of tumour necrosis factor (TNF) within a mandibular osteitis lesion observed in SAPHO syndrome, suggesting TNF involvement in the genesis or maintenance of osteoarticular damage. Familial forms have been described. The predisposing genetic background appears to be similar to that of spondyloarthropathy, since the HLA B27 antigen is found in 4% to 18% of cases of SAPHO syndrome. However, results in different series remain discordant, and the role of this antigen remains controversial. The frequent association of Crohn’s disease (CD) with SAPHO syndrome reinforces the hypothesis of a genetic mechanism via mutation of the NOD2/CARD15 gene [<xref ref-type="bibr" rid="scirp.131052-ref1">1</xref>] .</p><p>There is no well-coded treatment for SAPHO syndrome. It is essentially based on NSAIDs (non-steroidal anti-inflammatory drugs) or sulphonamides such as sulfasalazine. Dosage must be adapted to each individual patient, taking side effects into account [<xref ref-type="bibr" rid="scirp.131052-ref2">2</xref>] .</p><p>Their efficacy is often inadequate, which explains why they are generally combined with other treatments (sulfasalazine or methotrexate). A drug in the bisphosphonate class (pamidronate) has shown favourable action not only on pain, but also on pustular lesions [<xref ref-type="bibr" rid="scirp.131052-ref8">8</xref>] .</p><p>Corticosteroids should only be prescribed very rarely, and are only indicated in emergencies and for a very limited duration. There have been a few trials with various immunomodulators, including anti-TNF-alpha. In most cases, treatment with methotrexate is initiated [<xref ref-type="bibr" rid="scirp.131052-ref2">2</xref>] .</p><p>The disease never progresses to carcinogenesis. In some people, symptoms may even disappear spontaneously, but in all cases the evolution is unpredictable [<xref ref-type="bibr" rid="scirp.131052-ref8">8</xref>] .</p><p>Therapeutic evaluation is difficult, in the absence of strict controlled studies. To date, treatment of SAPHO remains symptomatic. However, the management of SAPHO needs to be multidisciplinary [<xref ref-type="bibr" rid="scirp.131052-ref2">2</xref>] .</p><p>The long-term prognosis of SAPHO syndrome is favourable, with remissions lasting several years followed by new exacerbations [<xref ref-type="bibr" rid="scirp.131052-ref6">6</xref>] .</p></sec><sec id="s4"><title>4. Conclusion</title><p>SAPHO syndrome, related to spondyloarthropathy, associates to varying degrees cutaneous and osteoarticular signs. Diagnosis is frequently delayed due to a lack of awareness of the syndrome. <sup>99m</sup>Tc-HMDP bone scintigraphy is an invaluable diagnostic tool, as isotope fixation can precede clinical and even radiological manifestations, particularly in the anterior thorax. Bone scintigraphy can also be useful in assessing the extent of damage and its progression.</p></sec><sec id="s5"><title>Conflicts of Interest</title><p>None.</p></sec><sec id="s6"><title>Cite this paper</title><p>Bathily, E.H.A.L., Gueye, K., Badiane, S.M., Djigo, M.S., Thiaw, G., Diop, O., Fachinan, O.H., Sy, P.M., Djiboune, A.R., Adambounou, K.F.T., Diouf, L.A.D., Ndong, B., Mbaye, G., Ndoye, O., Diarra, M. and Mbodj, M. (2024) Contribution of Bone Scintigraphy in the Diagnosis of a Case of SAPHO in the Nuclear Medicine Department of Idrissa Pouye General Hospital (Dakar, Senegal). Open Journal of Medical Imaging, 14, 1-9. https://doi.org/10.4236/ojmi.2024.141001</p></sec></body><back><ref-list><title>References</title><ref id="scirp.131052-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Gharsallah, I., Souissi, A., et al. (2014) Le syndrome SAPHO. La Revue de Médecine Interne, 35, 595-600. https://doi.org/10.1016/j.revmed.2013.12.018</mixed-citation></ref><ref id="scirp.131052-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Schilling, F. (2004) Le syndrome SAPHO. Encyclopedie Orphanet, Octobre. http://www.orpha.net/data/patho/FR/fr-sapho.pdf</mixed-citation></ref><ref id="scirp.131052-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Sturque, J., et al. (2016) Le r&amp;#244;le de l’odontologiste dans le cadre du syndrome SAPHO: cas cliniques et revue de la littérature des signes oro-faciaux. Med Buccale Chir Buccale, 22, 305-311. https://doi.org/10.1051/mbcb/2016039</mixed-citation></ref><ref id="scirp.131052-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Ghomari, C., et al. (2023) Apport de la TEMP/TDM osseuse dans le diagnostic d’un syndrome SAPHO au stade précoce: à propos d’un cas. Médecine Nucléaire, 47, 75-101. https://doi.org/10.1016/j.mednuc.2023.01.074</mixed-citation></ref><ref id="scirp.131052-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Merilahti, K.P., et al. (1996) Propionibacterium acnes isolated from sternal osteitis in a patient with SAPHO syndrome. The Journal of Rheumatology, 23, 1302-1304.</mixed-citation></ref><ref id="scirp.131052-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Przybylowski, S. (2021) L’utilisation des biothérapies dans le syndrome SAPHO. Thèse de Dipl&amp;#244;me d’état de docteur en pharmacie, Université Rennes 1, Bretagne Loire.</mixed-citation></ref><ref id="scirp.131052-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Haddouche, A., et al. (2015) Syndrome SAPHO—Origine microbienne? Revue Marocaine de Rhumatologie, 31, 12-19.</mixed-citation></ref><ref id="scirp.131052-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Ndong, B., et al. (2010) Apport de la scintigraphie osseuse dans le diagnostic des arthrites inflammatoires rares: à propos d’un cas de syndrome de Sapho à l’H&amp;#244;pital Général de Grand Yoff. Médecine Nucléaire, 34S, e39-e41.https://doi.org/10.1016/j.mednuc.2010.07.010</mixed-citation></ref><ref id="scirp.131052-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Colina, M., Govoni, M., et al. (2009) Clinical and Radiologic Evolution of Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis Syndrome: A Single Center Study of a Cohort of 71 Subjects. Arthritis &amp; Rheumatology, 61, 813-821. https://doi.org/10.1002/art.24540</mixed-citation></ref><ref id="scirp.131052-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Assmann, G. and Simon, P. (2011) The SAPHO Syndrome—Are Microbes Involved? Best Practice &amp; Research Clinical Rheumatology, 25, 423-434. https://doi.org/10.1016/j.berh.2011.01.017</mixed-citation></ref><ref id="scirp.131052-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Chamot, A.M., et al. (1987) Le syndrome acné pustulose hyperostose ostéite (SAPHO): Résultats d’une enquête nationale. Revue du Rhumatisme, 54, 187-196.</mixed-citation></ref><ref id="scirp.131052-ref12"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hayem</surname><given-names> G. </given-names></name>,<etal>et al</etal>. (<year>2004</year>)<article-title>Syndrome SAPHO</article-title><source> La Lettre du Rhumatologue</source><volume> 36</volume>,<fpage> 24</fpage>-<lpage>33</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.131052-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Miyamoto, M., Shirai, Y., Nakayama, Y., Gembun, Y. and Kaneda, K. (2000) A Case Report of Synovitis Acne Pustulosis Hyperostosis and Osteitis Syndrome Presenting with Spondylodiscitis. Journal of Nippon Medical School, 67, 191-197. https://doi.org/10.1272/jnms.67.191</mixed-citation></ref><ref id="scirp.131052-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Boutin, R.D. and Resnick, D. (1998) The SAPHO Syndrome: An Evolving Concept for Unifying Several Idiopathic Disorders of Bone and Skin. American Journal of Roentgenology, 170, 585-591. https://doi.org/10.2214/ajr.170.3.9490935</mixed-citation></ref><ref id="scirp.131052-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Paycha, F. and Richard, B. (2001) Exploration scintigraphique du squelette. Encycl Méd Chir (Editions Scientifiques et Médicales Elsevier SAS, Paris), Radiodiagnostic - Squelette Normal, 30-480-A-10, 37 p.</mixed-citation></ref><ref id="scirp.131052-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Maugars, Y., Berthelot, J.M., et al. (1995) SAPHO Syndrome: A Follow-Up Study of 19 Cases with Special Emphasis on Enthesis Involvement. The Journal of Rheumatology, 22, 2135-2141.</mixed-citation></ref><ref id="scirp.131052-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Prost, A., Dupas, B., et al. (1980) Hyperostose sterno-costo-claviculaire. à propos de deux observations dont une forme partielle. Journal de Radiologie, 61, 807-812.</mixed-citation></ref></ref-list></back></article>